Company Analysis

Lucid Diagnostics Inc. (LUCD)

Nasdaq: LUCD · Surgical & Medical Instruments & Apparatus · New York, NY · filing with the SEC since 2020
Grade3.4
◀ Past 3.6● Present 2.5▶ Future 4.3
4 est.

Filings

204 filings since 2017 beside 79 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026
Due next and emerging growth company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 43 days after the quarter ended. The proxy statement was last filed Apr 30, 2026.

Filings a yearinsider forms included
2385243535540
2020202120222023202420252026

2026 counts to Nov 13, 2026.

Listing warning from its exchange (8-K item 3.01): 4 times in the last 36 months, the newest Oct 16, 2026.Officer or director change (8-K item 5.02): 3 times in the last 36 months, the newest Sep 25, 2025.Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest Apr 25, 2025.SEC letters: 5 in the last 36 months, the newest Mar 25, 2026.
Insider forms 79

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 12, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Nov 12, 2026 10-Q Quarterly report Sep 30, 2026
Oct 22, 2026 8-K items 3.02, 3.03, 5.03, 9.01 Shares sold without registration; Change to shareholders' rights; Charter, bylaw or fiscal-year change · Current report Oct 21, 2026
Oct 16, 2026 8-K items 3.01, 9.01 Listing warning from its exchange · Current report Oct 12, 2026
Sep 22, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Aug 13, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Aug 12, 2026 10-Q Quarterly report Jun 30, 2026
Jun 24, 2026 8-K items 5.03, 5.07, 9.01 Charter, bylaw or fiscal-year change; Shareholder vote · Current report
May 14, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
May 13, 2026 10-Q Quarterly report Mar 31, 2026
Apr 30, 2026 DEFA14A Extra proxy material
Apr 30, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 30, 2026 DEF 14A Proxy statement
Apr 24, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Apr 23, 2026 424B5 Shelf offering
Apr 23, 2026 8-K items 1.01, 7.01, 9.01 Major agreement signed; Investor disclosure (Regulation FD) · Current report
Apr 20, 2026 PRE 14A Preliminary proxy statement
Apr 3, 2026 S-8 Employee stock plan registration
Apr 3, 2026 S-8 Employee stock plan registration
Mar 26, 2026 EFFECT Registration effective
Mar 26, 2026 424B5 Shelf offering
Mar 26, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Mar 26, 2026 S-3/A Shelf registration, amended
Mar 25, 2026 CORRESP Reply to the SEC
Mar 25, 2026 10-K Annual report Dec 31, 2025
Feb 9, 2026 SCHEDULE 13D/A Activist holder update, amended
Dec 5, 2025 S-3 Shelf registration
Nov 12, 2025 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Nov 12, 2025 10-Q Quarterly report Sep 30, 2025
Oct 10, 2025 SCHEDULE 13D/A Activist holder update, amended
Sep 25, 2025 8-K items 5.02, 7.01, 9.01 Officer or director change; Investor disclosure (Regulation FD) · Current report Sep 22, 2025
Sep 11, 2025 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Sep 10, 2025 424B5 Shelf offering
Sep 10, 2025 8-K items 1.01, 7.01, 9.01 Major agreement signed; Investor disclosure (Regulation FD) · Current report
Sep 9, 2025 424B5 Shelf offering
Aug 13, 2025 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Aug 12, 2025 10-Q Quarterly report Jun 30, 2025
Jun 18, 2025 8-K items 5.07, 9.01 Shareholder vote · Current report
Jun 3, 2025 424B3 Shelf offering
May 30, 2025 EFFECT Registration effective
40 of 204 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton LUCD · research, not advice